Welcome to LookChem.com Sign In|Join Free

CAS

  • or

68573-24-0

Post Buying Request

68573-24-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68573-24-0 Usage

Description

N-(p-Coumaroyl) Serotonin is an antioxidative phenolic compound naturally found in plants, such as safflower seed and millet grain. It possesses potent antioxidant properties and plays a crucial role in atherosclerosis prevention and treatment.

Uses

Used in Cardiovascular Health Applications:
N-(p-Coumaroyl) Serotonin is used as an anti-atherosclerotic agent for its ability to ameliorate atherosclerosis in vivo, reducing lesion area in mice and rabbits. This makes it a promising candidate for the prevention and treatment of cardiovascular diseases.
Used in Anti-Inflammatory Applications:
N-(p-Coumaroyl) Serotonin is used as an anti-inflammatory agent for its ability to suppress the generation of inflammatory cytokines by human monocytes. This property can be beneficial in managing inflammation-related conditions.
Used in Wound Healing Applications:
N-(p-Coumaroyl) Serotonin is used as a wound healing promoter for its ability to augment fibroblast proliferation. This can enhance the healing process of various types of wounds and injuries.
Used in Vascular Health Applications:
N-(p-Coumaroyl) Serotonin is used as a vascular smooth muscle cell relaxant for its ability to promote relaxation of vascular smooth muscle cells in vitro. This can contribute to improved blood flow and overall vascular health.

Check Digit Verification of cas no

The CAS Registry Mumber 68573-24-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,5,7 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 68573-24:
(7*6)+(6*8)+(5*5)+(4*7)+(3*3)+(2*2)+(1*4)=160
160 % 10 = 0
So 68573-24-0 is a valid CAS Registry Number.
InChI:InChI=1/C19H18N2O3/c22-15-4-1-13(2-5-15)3-8-19(24)20-10-9-14-12-21-18-7-6-16(23)11-17(14)18/h1-8,11-12,21-23H,9-10H2,(H,20,24)/b8-3+

68573-24-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(p-Coumaroyl) Serotonin

1.2 Other means of identification

Product number -
Other names ipobscurine A

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68573-24-0 SDS

68573-24-0Relevant articles and documents

Synthesis of amide and ester derivatives of cinnamic acid and its analogs: Evaluation of their free radical scavenging and monoamine oxidase and cholinesterase inhibitory activities

Takao, Koichi,Toda, Kazuhiro,Saito, Takayuki,Sugita, Yoshiaki

, p. 1020 - 1027 (2017/11/17)

A series of cinnamic acid derivatives, amides (1–12) and esters (13–22), were synthesized, and structure–activity relationships for antioxidant activity, and monoamine oxidases (MAO) A and B, acetylcholinesterase, and butyrylcholinesterase (BChE) inhibitory activities were analyzed. Among the synthesized compounds, compounds 1–10, 12–18, and rosmarinic acid (23), which contained catechol, o-methoxyphenol or 5-hydroxy-indole moieties, showed potent 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activity. Compounds 9–11, 15, 17–22 showed potent and selective MAO-B inhibitory activity. Compound 20 was the most potent inhibitor of MAO-B. Compounds 18 and 21 showed moderate BChE inhibitory activity. In addition, compound 18 showed potent antioxidant activity and MAO-B inhibitory activity. In a comparison of the cinnamic acid amides and esters, the amides exhibited more potent DPPH free radical scavenging activity, while the esters showed stronger inhibitory activities against MAO-B and BChE. These results suggested that cinnamic acid derivatives such as compound 18, p-coumaric acid 3,4-dihydroxyphenethyl ester, and compound 20, p-coumaric acid phenethyl ester, may serve as lead compounds for the development of novel MAO-B inhibitors and candidate lead compounds for the prevention or treatment of Alzheimer’s disease.

TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN GASTROPATHY

-

Page/Page column 20-21; 22-23, (2012/04/04)

The present invention concerns the synthesis and evaluation of gastroprotective effect of different tryptamine derivatives. Tryptamine derivatives have been synthesized by formation of amide or ester with some known anti oxidant molecules. These derivatives show excellent antioxidant property in vitro. Among all the derivatives the compound SEGA (3 a), that was prepared by the combination of serotonin with gallic acid shows the greater antioxidant property than the other synthesized compounds both in vivo and in vitro. SEGA(3a) shows the gastroprotective effect against NSAIDs (indomethacin or diclofenac)-induced gastropathy in dose dependent manner and also accelerates the healing from injury. It prevents the NSAIDs-induced mitochondrial oxidative stress in vivo. This derivative prevents NSAID-induced mitochondrial oxidative stress-mediated apoptosis in vivo by preventing the activation of caspase 9 and caspase-3 and restores NSAIDs-mediated collapse of mitochondroial transmembrane potential and dehydrogenase activity. SEGA (3 a) plays an important role as an iron chelator as well as intra mitochondrial ROS scavenger. Thus, SEGA (3 a) is a potent antioxidant antiapototic molecule, which efficiently prevents NSAID-induced gastropathy and stress or alcohol -mediated gastric damage.

Syntheses of 1-hydroxytryptamines and serotonins having fattyacyl or (E)-3-phenylpropenoyl derivatives as a Nb-substituent, and a novel homologation on the 3-substituent of the 1-hydroxytryptamines upon treatment with diazomethane

Somei, Masanori,Morikawa, Harunobu,Yamada, Koji,Yamada, Fumio

, p. 1117 - 1120 (2007/10/03)

1-Hydroxytryptamines (6a-f) having (E)-3-phenyl-, (E)-3-(4-hydroxyphenyl)-, (E)-3-(4-hydroxy-3-methoxyphenyl)propenoyl, octanoyl, hexadecanoyl, and docosanoyl group as a Nb-substituent are prepared for the first time. Preparations of serotonins (2a-c, e)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68573-24-0